Search
We still do not have a RF vaccine, although the recent announcement that the Australian and New Zealand governments are jointly sponsoring a program to fast...
The Indigenous population of the Northern Territory of Australia (NT) suffers from a very high burden of Streptococcus pyogenes disease, including cardiac...
In the 21st century, rheumatic fever (RF) and rheumatic heart disease (RHD) are neglected diseases of marginalized communities.
Immediate plating of impetigo swabs is the gold standard for bacterial recovery but is rarely feasible in remote regions.
The median number of presentations per child in the first year of life was 21 with multiple reasons for presentation.
In endemic areas, RHD has long been a target of screening programmes that, historically, have relied on cardiac auscultation.
Group A Streptococcus (Strep A) causes a wide spectrum of diseases, ranging from pharyngitis and impetigo to severe invasive infections and immune-mediated conditions such as acute rheumatic fever, rheumatic heart disease and acute post-streptococcal glomerulonephritis. Contemporary data on the global burden of Strep A diseases are lacking.
This scoping review explores existing clinical guidelines on administration of benzathine benzylpenicillin (Bicillin L-A, Pfizer Australia) in Australia and Aotearoa New Zealand. The objective is to understand existing delivery guidance to address variation in care and cultural safety considerations, to support messaging during periods of stockout and to inform planning for new administration techniques.
Language is significant for communicating knowledge across cultures and generations and has the power to attribute meanings and alter our worldviews.
This study provides new knowledge on ARF characteristics and management and highlights international variation in diagnostic and management practice.